Go Premium in Our Biggest Sale EverUPGRADE NOW
TipRanks
Go Ultimate75% OFF

Amy Schulman Insider Profile

11 Followers

Amy Schulman, Director at Alnylam Pharma, holds 24.05K shares in Alnylam Pharma (Ticker: ALNY), holds 781.00 shares in Elevance Health (Ticker: ELV), holds 8.55K shares in Fractyl Health, Inc. (Ticker: GUTS).

Amy Schulman's Trading History

ALNYAlnylam Pharma		May 22, 2026DirectorUninformative Buy―$3.75M
ELVElevance Health		May 15, 2026DirectorUninformative Buy―$332.41K
GUTSFractyl Health, Inc.		Mar 17, 2025DirectorInformative Buy9.92K$7.94K
SQZBSQZ Biotechnologies		Dec 23, 2021Director, Ten Percent OwnerUninformative Buy84.82K$77.33K
KRSAKorsana Biosciences		Apr 10, 2019DirectorInformative Buy10.02M$19.67M
IRWDIronwood Pharma		Apr 03, 2019DirectorUninformative Sell―$167.88K
~BUFFBlue Buffalo		Apr 24, 2018―Uninformative Sell―$0.00
PFEPfizer		May 16, 2013Former Exec. Vice PresidentUninformative Sell2.06M$6.67M
ZTSZoetis		Feb 08, 2013DirectorInformative Buy130.00K$397.00K
BINDQDNIB Unwind, Inc.		―――$0.00
XFORX4 Pharmaceuticals		―Director――
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Amy Schulman insider profile FAQ

What is the percentage of profitable transactions made by Amy Schulman?
The percentage of profitable transactions made by Amy Schulman is 0%.
What is the average return per transaction made by Amy Schulman?
The average return per transaction made by Amy Schulman is -60.40%.
What stocks does Amy Schulman hold?
Amy Schulman holds: ALNY, IRWD, ELV, ~BUFF, XFOR, KRSA, SQZB, GUTS, BINDQ, PFE, ZTS stocks.
What was Amy Schulman's most profitable transaction?
Amy Schulman’s most profitable transaction was an Informative Buy of SQZB stock on November 3, 2020. The return on the trade was -14.60%.
What is Amy Schulman's role in Alnylam Pharma?
Amy Schulman's role in Alnylam Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.